← The Wire
NUVBNYSE
Nuvation Bio Inc.
Pharmaceutical Preparations · DE · CIK 1811063
Nuvation Bio Inc. is a global oncology company developing novel small molecule therapies for cancer
$1.71B
Market cap
$5.61
Last close
-0.7%
1D
-2.6%
5D
10.7M
Volume
Price · last 39 sessions+27.2%
May 4L $4.21 · H $6.46Jun 29
116
Total filings
Jun 29, 2026
Last filing
12/31
Fiscal year end
424B5424B5Jun 29, 2026424B5424B5Jun 25, 20268-KShareholder VoteMay 27, 20268-KResults of OperationsMay 4, 202610-Q10-QMay 4, 2026DEFA14ADEFA14AApr 21, 2026DEF 14ADEF 14AApr 10, 202610-K10-KMar 2, 20268-KResults of OperationsMar 2, 20268-KMaterial Agreement · Results of OperationsJan 12, 20268-KReg FD Disclosure · Company UpdateNov 26, 20258-KReg FD Disclosure · Company UpdateNov 17, 202510-Q10-QNov 3, 20258-KResults of OperationsNov 3, 202510-Q10-QAug 7, 20258-KResults of OperationsAug 7, 20258-KReg FD Disclosure · Company UpdateJun 11, 20258-KShareholder VoteMay 23, 202510-Q10-QMay 7, 20258-KResults of OperationsMay 7, 2025DEF 14ADEF 14AApr 8, 20258-KMaterial AgreementMar 25, 202510-K10-KMar 6, 20258-KResults of OperationsMar 6, 20258-KMaterial AgreementMar 5, 20258-KMaterial Agreement · New Debt / ObligationMar 4, 20258-KExecutive ChangeFeb 12, 20258-KResults of OperationsNov 6, 202410-Q10-QNov 6, 20248-KExecutive ChangeOct 7, 2024SC 13DSC 13DSep 10, 20248-KShareholder Vote · Company UpdateSep 5, 202410-Q10-QAug 5, 20248-KResults of OperationsAug 5, 2024DEF 14ADEF 14AJul 30, 20248-K/ACompany UpdateJun 20, 202410-Q10-QMay 14, 20248-KResults of OperationsMay 14, 202410-K/A10-K/AApr 26, 20248-KExecutive Change · Material AgreementApr 10, 20248-KMaterial Agreement · Equity IssuanceMar 25, 202410-K10-KFeb 29, 20248-KResults of OperationsFeb 29, 2024SC 13GSC 13GJan 29, 20248-KExecutive ChangeJan 8, 20248-KExecutive ChangeDec 14, 20238-KExecutive ChangeNov 27, 20238-KExecutive ChangeNov 13, 20238-KResults of OperationsNov 2, 202310-Q10-QNov 2, 202310-Q10-QAug 3, 20238-KResults of OperationsAug 3, 20238-KShareholder VoteMay 16, 202310-Q10-QMay 4, 20238-KResults of OperationsMay 4, 2023DEF 14ADEF 14AApr 4, 202310-K10-KMar 15, 20238-KResults of OperationsMar 15, 20238-KCompany UpdateMar 2, 2023SC 13GSC 13GFeb 13, 20238-KReg FD DisclosureDec 23, 202210-Q10-QNov 3, 20228-KResults of OperationsNov 3, 202210-Q10-QAug 4, 20228-KResults of OperationsAug 4, 20228-KResults of Operations · Exit / Disposal CostsAug 1, 2022SC 13GSC 13GJun 23, 20228-KShareholder VoteMay 17, 202210-Q10-QMay 9, 20228-KResults of OperationsMay 9, 2022DEF 14ADEF 14AApr 4, 20228-KResults of OperationsFeb 28, 202210-K10-KFeb 28, 20228-KResults of OperationsJan 10, 20228-KReg FD DisclosureJan 10, 202210-Q10-QNov 10, 20218-KResults of OperationsNov 10, 20218-KAgreement TerminatedOct 28, 202110-Q10-QAug 12, 20218-KResults of OperationsAug 12, 2021
Insider Activity
In the 90 days to Dec 1, 2025: 3 sold $6.2M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 1, 2025 | Liu DongfangCHIEF MEDICAL OFFICER | Sell | 150,000 | $7.82 | $1.2M |
| Nov 26, 2025 | Liu DongfangCHIEF MEDICAL OFFICER | Sell | 10,000 | $8.00 | $80K |
| Nov 25, 2025 | Liu DongfangCHIEF MEDICAL OFFICER | Sell | 10,000 | $7.50 | $75K |
| Nov 20, 2025 | Hattersley GaryCHIEF SCIENTIFIC OFFICER | Sell | 300,000 | $7.23 | $2.2M |
| Nov 20, 2025 | Hattersley GaryCHIEF SCIENTIFIC OFFICER | Sell | 69,051 | $7.23 | $499K |
| Nov 20, 2025 | Liu DongfangCHIEF MEDICAL OFFICER | Sell | 20,000 | $7.00 | $140K |
| Nov 19, 2025 | Hanley David C.CHIEF TECHNICAL OPERATIONS | Sell | 200,000 | $7.14 | $1.4M |
| Nov 19, 2025 | Liu DongfangCHIEF MEDICAL OFFICER | Sell | 15,000 | $5.10 | $77K |
| Nov 17, 2025 | Liu DongfangCHIEF MEDICAL OFFICER | Sell | 15,000 | $4.77 | $72K |
| Oct 27, 2025 | Hattersley GaryCHIEF SCIENTIFIC OFFICER | Sell | 100,000 | $5.02 | $502K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance